Cassava Sciences, Inc. (SAVA)
3.15
-0.11
(-3.37%)
USD |
NASDAQ |
Dec 11, 16:00
3.15
0.00 (0.00%)
After-Hours: 20:00
Cassava Sciences Cash from Investing (Quarterly): -0.08M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen, Inc. | -35.10M |
| Geron Corp. | 13.35M |
| Ovid Therapeutics, Inc. | 5.053M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.221M |
| Free Cash Flow | -83.91M |
| Free Cash Flow Per Share (Quarterly) | -0.1304 |
| Free Cash Flow to Equity (Quarterly) | -6.301M |
| Free Cash Flow to Firm (Quarterly) | -6.301M |
| Free Cash Flow Yield | -55.21% |